Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Klug, Gert ^a   Mayr, Agnes ^a   Schenk, Sonja ^a   Esterhammer, Regina ^a   Schocke, Michael ^a   Nocker, Michael ^a   Jaschke, Werner ^a   Pachinger, Otmar ^a   Metzler, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cardiaovascular magnetic resonance; Cardiovascular outcome; Microvascular obstruction; Myocardial infarction

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REPEAT PROCEDURE; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CORONARY OCCLUSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84863665386     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-46     Document Type: Article

References (52)

1. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Jaffe R, Charron T, Puley G, Dick A, Strauss BH, Circulation 2008 117 3152 6 10.1161/CIRCULATIONAHA.107.742312 18559715
2. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. Kloner RA, Ganote CE, Jennings RB, J Clin Invest 1974 54 1496 508 10.1172/JCI107898 4140198
3. Myocardial reperfusion: a double-edged sword? Braunwald E, Kloner RA, J Clin Invest 1985 76 1713 9 10.1172/JCI112160 4056048 (Pubitemid 16196036)
4. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. Gibson CM, Ryan KA, Murphy SA, Mesley R, Marble SJ, Giugliano RP, et al. J Am Coll Cardiol 1999 34 974 82 10.1016/S0735-1097(99)00335-6 10520778 (Pubitemid 29500526)
5. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. Roe MT, Ohman EM, Maas AC, Christenson RH, Mahaffey KW, Granger CB, et al. J Am Coll Cardiol 2001 37 9 18 10.1016/S0735-1097(00)01101-3 11153779 (Pubitemid 32051713)
6. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Circulation 2000 101 125 30 10.1161/01.CIR.101.2.125 10637197 (Pubitemid 30044249)
7. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. van t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F, Circulation 1998 97 2302 6 10.1161/01.CIR.97.23.2302 9639373 (Pubitemid 28280383)
8. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, et al. Am Heart J. 2004 148 336 40 10.1016/j.ahj.2003.12.044 15309006 (Pubitemid 39092802)
9. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA, Potential mechanisms. Circulation. 1995 92 1117 25
10. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, et al. Circulation 1995 92 1902 10 10.1161/01.CIR.92.7.1902 7671375
11. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, et al. Eur Heart J. 2005 26 549 57 15713695 (Pubitemid 40461096)
12. Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging. Klug G, Trieb T, Schocke M, Nocker M, Skalla E, Mayr A, et al. J Magn Reson Imaging 2009 29 298 304 10.1002/jmri.21498 19161193
13. Patterns of myocardial perfusion in the acute and chronic stage after myocardial infarction: A cardiac magnetic resonance study. Trieb T, Mayr A, Klug G, Runge A, Pedarnig K, Pachinger O, et al. Eur J Radiol 2012 81 767 72 10.1016/j.ejrad.2011.01.069 21439747
14. Late microvascular obstruction after acute myocardial infarction: Relation with cardiac and inflammatory markers. Mayr A, Klug G, Schocke M, Trieb T, Mair J, Pedarnig K, et al. Int J Cardiol 2012 157 391 6 10.1016/j.ijcard. 2010.12.090 21239074
15. Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. Porto I, Burzotta F, Brancati M, Trani C, Lombardo A, Romagnoli E, et al. Am J Cardiol 2007 99 1671 3 10.1016/j.amjcard.2007.01.045 17560873 (Pubitemid 46874311)
16. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC, et al. J Am Coll Cardiol 1998 32 1756 64 10.1016/S0735-1097(98)00429-X 9822106 (Pubitemid 28560223)
17. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Chest 2002 122 1322 32 10.1378/chest.122.4.1322 12377860 (Pubitemid 35339548)
18. Predictors of myocardial microvascular obstruction in patients treated by primary percutaneous coronary intervention and a short ischemic time. Niccoli G, Spaziani C, Cosentino N, Lombardo A, Fracassi F, Cataneo L, et al. Int J Cardiol 2011 153 113 5 10.1016/j.ijcard.2011.09.035 21975355
19. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Circulation 1998 97 765 72 10.1161/01.CIR.97.8.765 9498540 (Pubitemid 28135339)
20. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. de Waha S, Desch S, Eitel I, Fuernau G, Zachrau J, Leuschner A, et al. Eur Heart J 2010 31 2660 8 10.1093/eurheartj/ehq247 20675660
21. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW, Eur Heart J. 2006 27 2400 5 10.1093/eurheartj/ehl094 16782719 (Pubitemid 44522145)
22. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW, J Am Coll Cardiol 2005 45 1775 80 10.1016/j.jacc.2005.02.061 15936605 (Pubitemid 40779856)
23. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E, et al. Circulation 2008 118 49 57 10.1161/CIRCULATIONAHA.107.747642 18559698
24. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F, Eur Heart J. 2008 29 3002 10 10.1093/eurheartj/ehn389 18775918
25. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. Jaffe R, Dick A, Strauss BH, JACC Cardiovasc Interv. 2010 3 695 704 10.1016/j.jcin.2010.05.004 20650430
26. Rationale and design of the INFUSE-AMI study: A 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, et al. Am Heart J 2011 161 478 86 e7 10.1016/j.ahj.2010.10.006 21392601
27. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Alpert JS, Thygesen K, Antman E, Bassand JP, J Am Coll Cardiol 2000 36 959 69 10.1016/S0735-1097(00)00804-4 10987628
28. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function. Mayr A, Mair J, Schocke M, Klug G, Pedarnig K, Haubner BJ, et al. Int J Cardiol 2011 147 118 23 10.1016/j.ijcard.2009.09.537 19896736
29. Analysis of serial measurements in medical research. Matthews JN, Altman DG, Campbell MJ, Royston P, BMJ 1990 300 230 5 10.1136/bmj.300.6719.230 2106931 (Pubitemid 20045528)
30. Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI. Klug G, Mayr A, Mair J, Schocke M, Nocker M, Trieb T, et al. Clin Res Cardiol 2011 100 501 10 10.1007/s00392-010-0273-0 21203766
31. Evaluation of transient apical ballooning with cardiac magnetic resonance imaging and 31-phosphorous magnetic resonance spectroscopy. Klug G, Wolf C, Trieb T, Frick M, Koehler A, Schocke MF, et al. Int J Cardiol 2007 118 249 52 10.1016/j.ijcard.2006.06.060 17049390 (Pubitemid 46601655)
32. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, et al. J Am Coll Cardiol 2003 42 895 901 10.1016/S0735-1097(03)00835-0 12957439 (Pubitemid 37059750)
33. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, et al. J Cardiovasc Magn Reson 2005 7 481 5 10.1081/JCMR-200053623 15881532 (Pubitemid 40563339)
34. Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction. Nowosielski M, Schocke M, Mayr A, Pedarnig K, Klug G, Kohler A, et al. J Cardiovasc Magn Reson 2009 11 22 10.1186/1532-429X-11-22 19589148
35. Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI. Husser O, Bodi V, Sanchis J, Nunez J, Lopez-Lereu MP, Monmeneu JV, et al. Int J Cardiol 2011 Oct 2011. Epub ahead of print
36. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, et al. Clin Res Cardiol 2011 100 649 59 10.1007/s00392-011-0290-7 21347741
37. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Panza JA, Quyyumi AA, Brush JE, Epstein SE, N Engl J Med 1990 323 22 7 10.1056/NEJM199007053230105 2355955 (Pubitemid 20209468)
38. Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging. de Waha S, Desch S, Eitel I, Fuernau G, Lurz P, Leuschner A, et al. Clin Res Cardiol 2012 101 6 487 495 10.1007/s00392-012-0419-3 22314277
39. Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study. Mayr A, Pedarnig K, Klug G, Schocke M, Pachinger O, Jaschke W, et al. Int J Cardiovasc Imaging. 2011 Oct 1 Epub ahead of print
40. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Kim RJ, Chen EL, Lima JA, Judd RM, Circulation 1996 94 3318 26 10.1161/01.CIR.94.12.3318 8989146 (Pubitemid 26427504)
41. Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. Mather AN, Lockie T, Nagel E, Marber M, Perera D, Redwood S, et al. J Cardiovasc Magn Reson 2009 11 33 10.1186/1532-429X-11-33 19698105
42. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Klem I, Shah DJ, White RD, Pennell DJ, van Rossum AC, Regenfus M, et al. Circ Cardiovasc Imaging. 2011 4 610 9 10.1161/CIRCIMAGING. 111.964965 21911738
43. Effect of coronary collaterals on microvascular obstruction as assessed by magnetic resonance imaging in patients with acute ST-elevation myocardial infarction treated by primary coronary intervention. Desch S, Eitel I, Schmitt J, Sareban M, Fuernau G, Schuler G, et al. Am J Cardiol 2009 104 1204 9 10.1016/j.amjcard.2009.06.031 19840563
44. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A, J Am Coll Cardiol 2002 39 847 51 10.1016/S0735-1097(02)01690-X 11869851 (Pubitemid 34185333)
45. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Pries AR, Habazettl H, Ambrosio G, Hansen PR, Kaski JC, Schachinger V, et al. Cardiovasc Res 2008 80 165 74 10.1093/cvr/cvn136 18511433
46. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty. Sambuceti G, Marzilli M, Fedele S, Marini C, L'Abbate A, Circulation 2001 103 2352 60 10.1161/01.CIR.103.19.2352 11352883 (Pubitemid 32448799)
47. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. Marzilli M, Sambuceti G, Fedele S, L'Abbate A, J Am Coll Cardiol 2000 35 327 34 10.1016/S0735-1097(99)00554-9 10676677 (Pubitemid 30125521)
48. International variation in and factors associated with hospital readmission after myocardial infarction. Kociol RD, Lopes RD, Clare R, Thomas L, Mehta RH, Kaul P, et al. JAMA. 2012 307 66 74 10.1001/jama.2011.1926 22215167
49. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS, Eur Heart J. 2005 26 350 6 10.1093/eurheartj/ehi064 15618041 (Pubitemid 40287380)
50. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Schmitt J, Duray G, Gersh BJ, Hohnloser SH, Eur Heart J. 2009 30 1038 45 10.1093/eurheartj/ehn579 19109347
51. Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction. Aronson D, Mutlak D, Bahouth F, Bishara R, Hammerman H, Lessick J, et al. Am J Cardiol 2011 107 1738 43 10.1016/j.amjcard.2011.02.334 21497781
52. Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging study. Lombardo A, Niccoli G, Natale L, Bernardini A, Cosentino N, Bonomo L, et al. Int J Cardiovasc Imaging 2011 28 4 835 842 21643941